Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B6EA
|
|||
| Former ID |
DNCL002571
|
|||
| Drug Name |
NV-1020
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1/2 | [1] | |
| Company |
Catherex
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00149396) Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.